Patient data
. | Patient no. 1 . | Patient no. 2 . | Patient no. 3 . | Patient no. 4 . | Patient no. 5 . | Patient no. 6 . |
---|---|---|---|---|---|---|
Age, y | 50 | 49 | 24 | 26 | 47 | 17 |
Sex | Male | Female | Male | Male | Male | Male |
Diagnosis | FL | MM | CML | CML | MM | AML |
When cGVHD developed | After PBSCT | After PBSCT | After BMT | After DLI | After 2nd DLI | After DLI |
. | Patient no. 1 . | Patient no. 2 . | Patient no. 3 . | Patient no. 4 . | Patient no. 5 . | Patient no. 6 . |
---|---|---|---|---|---|---|
Age, y | 50 | 49 | 24 | 26 | 47 | 17 |
Sex | Male | Female | Male | Male | Male | Male |
Diagnosis | FL | MM | CML | CML | MM | AML |
When cGVHD developed | After PBSCT | After PBSCT | After BMT | After DLI | After 2nd DLI | After DLI |
FL indicates follicular lymphoma; MM, multiple myeloma; CML, chronic myeloid leukemia; AML, acute myeloid leukemia; PBSCT, allogeneic peripheral blood SCT; BMT, bone marrow transplantation; and DLI, donor lymphocyte infusion.